Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.820
+0.030 (1.08%)
At close: Dec 5, 2025
-22.31% (1Y)
| Market Cap | 544.92M |
| Revenue (ttm) | 741.27M |
| Net Income (ttm) | 32.43M |
| Shares Out | 193.24M |
| EPS (ttm) | 0.17 |
| PE Ratio | 16.54 |
| Forward PE | 14.98 |
| Dividend | 0.13 (4.48%) |
| Ex-Dividend Date | Sep 1, 2025 |
| Volume | 408,479 |
| Average Volume | 665,294 |
| Open | 2.830 |
| Previous Close | 2.790 |
| Day's Range | 2.780 - 2.850 |
| 52-Week Range | 2.380 - 3.830 |
| Beta | 1.05 |
| RSI | 56.61 |
| Earnings Date | Feb 25, 2026 |